TOPIRAMATE | A220041 | RICONPHARMA LLC
No patent or exclusivity listings for this strength.
Riconpharma LLC received FDA approval for Topiramate (NDA 220041, strength 001).
New: New record
Riconpharma LLC received FDA approval (NDA 220041, supplemental application 002) for a topiramate product.
New: New record
Riconpharma LLC received FDA approval for topiramate (ANDA 220041, supplement 003), adding a new product record to the Orange Book.
New: New record
RICONPHARMA LLC received FDA approval for TOPIRAMATE (topiramate) under NDA 220041, supplement 004.
New: New record
Riconpharma LLC received FDA approval for Topiramate (ANDA 220041, supplement 005).
New: New record